Published in J Pathol on January 01, 2015
Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System. J Virol (2015) 0.82
Mumps virus-induced innate immune responses in mouse Sertoli and Leydig cells. Sci Rep (2016) 0.79
Remembering mumps. PLoS Pathog (2015) 0.77
Cross-Neutralization between Human and African Bat Mumps Viruses. Emerg Infect Dis (2016) 0.77
Establishing a small animal model for evaluating protective immunity against mumps virus. PLoS One (2017) 0.75
Mumps virus pathogenesis: Insights and knowledge gaps. Hum Vaccin Immunother (2016) 0.75
Mouse Testicular Cell Type-Specific Antiviral Response against Mumps Virus Replication. Front Immunol (2017) 0.75
Relation between the testicular sperm assay and sex hormone level in patients with azoospermia induced by mumps. Int J Clin Exp Med (2015) 0.75
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Mumps Virus SH protein inhibits NF-κB activation by interacting with TNFR1, IL-1R1, and TLR3 complexes. J Virol (2017) 0.75
Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers. Q J Med (1956) 8.00
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A (2004) 7.51
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19
Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet (1952) 3.56
Recent resurgence of mumps in the United States. N Engl J Med (2008) 2.90
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006. Vaccine (2008) 2.01
C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun (2001) 1.98
Mumps virus and subacute thyroiditis; evidence of a causal association. Lancet (1957) 1.97
CLINICAL AND LABORATORY STUDIES OF MUMPS. N Engl J Med (1964) 1.85
Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog (2011) 1.80
Vestibular symptoms in mumps deafness. Acta Otolaryngol Suppl (1979) 1.80
Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ (2006) 1.79
Inner ear pathology in deafness due to mumps. Ann Otol Rhinol Laryngol (1960) 1.79
Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75
RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol (1990) 1.68
Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med (1966) 1.66
Summary of notifiable diseases --- United States, 2005. MMWR Morb Mortal Wkly Rep (2007) 1.66
Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA (1973) 1.60
Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study. Lancet Glob Health (2013) 1.57
An office-based prospective study of deafness in mumps. Pediatr Infect Dis J (2009) 1.53
Mumps of the heart. Clinical and pathologic features. Circulation (1965) 1.52
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev (2001) 1.49
Perceptive deafness in connectionwith mumps. A study of 298 servicemen suffering from mumps. Acta Otolaryngol (1962) 1.49
The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology (1998) 1.46
The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol (2001) 1.46
The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol (1975) 1.45
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine (2004) 1.41
Brief report: update: mumps activity--United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep (2006) 1.35
Some implications of fatal nephritis associated with mumps. Am J Dis Child (1966) 1.34
Mumps epidemic--United kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep (2006) 1.32
Hearing loss due to mumps. Arch Dis Child (1987) 1.27
The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect (1987) 1.26
Experimental viral infections of the inner ear. I. Acute infections of the newborn hamster labyrinth. Lab Invest (1976) 1.26
Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science (1967) 1.24
Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med (1948) 1.20
Perinatal mumps infection. J Pediatr (1980) 1.18
Current status of mumps in the United States. J Infect Dis (1975) 1.17
Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation (1997) 1.17
Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17
Mumps III. Comparison of methods for detection of viruria. Proc Soc Exp Biol Med (1962) 1.16
Viremia in human mumps virus infections. AMA Arch Intern Med (1958) 1.14
Is mumps virus an etiologic factor in juvenile diabetes mellitus. J Pediatr (1975) 1.13
Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis (2008) 1.12
Epidemiology of mumps in the Netherlands. J Hyg (Lond) (1980) 1.10
AN INVESTIGATION OF THE ETIOLOGY OF MUMPS. J Exp Med (1934) 1.09
Intrauterine infection of the rhesus monkey with mumps virus: abbreviated viral replication in the immature fetus as an explanation for split immunologic recognition after birth. J Infect Dis (1972) 1.09
Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology (2011) 1.06
Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med (1970) 1.06
Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J Med Virol (1980) 1.05
Acute pancreatitis and haemolytic anaemia associated with mumps-virus infection. Br Med J (1965) 1.04
Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest (1974) 1.04
Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2. J Gen Virol (1990) 1.01
Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol (2009) 1.01
Granular ependymitis. Occurrence in myxovirus infected rodents and prevalence in man. Am J Pathol (1972) 1.01
The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol (2007) 0.99
Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch Virol (1978) 0.98
Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol (2000) 0.98
Mumps virus isolated from a fetus. Br Med J (Clin Res Ed) (1982) 0.97
Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine (2007) 0.97
Intrauterine infection with mumps virus. Obstet Gynecol (1980) 0.96
Ependymitis in mumps virus meningitis. Electron microscopical studies of cerebrospinal fluid. Arch Neurol (1974) 0.96
Mumps arthritis: a review of the literature. Rev Infect Dis (1984) 0.94
The isolation of mumps at autopsy. Am J Pathol (1949) 0.94
Observations on a mumps epidemic in a virgin population. Am J Hyg (1959) 0.94
Isolation of mumps virus from the inner ear after sudden deafness. Br Med J (1979) 0.94
Mumps meningoencephalitis in children. JAMA (1969) 0.93
A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine (2006) 0.92
Early ependymal changes in experimental hydrocephalus after mumps virus inoculation in hamsters. Acta Neuropathol (1993) 0.91
An outbreak of mumps in Sweden, February-April 2004. Euro Surveill (2005) 0.91
Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol (1998) 0.91
Reversible acute tetraventricular hydrocephalus complicating possible mumps meningoencephalitis. Pediatr Int (2007) 0.91
Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med (1973) 0.90
Mumps orchitis in the post-vaccine era (1967-2009): a single-center series of 67 patients and review of clinical outcome and trends. Medicine (Baltimore) (2010) 0.90
A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust (2009) 0.90
A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol (2009) 0.90
Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis (1976) 0.89
Mumps arthritis in children. Pediatr Infect Dis J (1990) 0.89
The epidemiology of mumps in southern Alberta 1980-1982. Am J Epidemiol (1989) 0.89
Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan. Vaccine (2010) 0.89
Mumps-induced corneal endotheliitis. Cornea (2004) 0.88
An increase in the number of mumps cases in the Czech Republic, 2005-2006. Euro Surveill (2008) 0.88
Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch Virol (1987) 0.88
Epididymitis in mumps, including orchitis: further clinical studies and comments. Ann Intern Med (1951) 0.88
Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. Euro Surveill (2009) 0.88
Mumps oophoritis: a cause of premature menopause. Fertil Steril (1975) 0.87
Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies. Epidemiol Infect (1989) 0.87
Mumps virus in human milk and in milk of infected monkey. J Am Med Assoc (1951) 0.87
Isolation of mumps virus from children with acute lower respiratory tract disease. Am J Epidemiol (1971) 0.86
Transmission of live, attenuated mumps virus to the human placenta. N Engl J Med (1974) 0.86
Genotyping and subtyping of mumps virus isolates from the Indian subcontinent. Arch Virol (2013) 0.85
Mumps virus may damage the vestibular nerve as well as the inner ear. Acta Otolaryngol (2008) 0.85
A case of fulminant type 1 diabetes associated with significant elevation of mumps titers. Endocr J (2008) 0.85
Evaluation of the neurovirulence test for mumps vaccines. Biologicals (1999) 0.84
Inclusion body myositis: the mumps virus hypothesis. Ann Neurol (1989) 0.84
Parotitis during pregnancy. Acta Obstet Gynecol Scand (1953) 0.84
Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanism. Vaccine (2010) 0.84
Hydrocephalus due to bilateral obstruction of the foramen of Monro: a 'possible' late complication of mumps encephalitis. Clin Neurol Neurosurg (1993) 0.84
Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate. J Virol (2013) 0.84
Genomic instability in mice lacking histone H2AX. Science (2002) 10.23
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab (2005) 4.79
Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol (2007) 4.09
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol (2005) 3.44
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Retro-orbital injections in mice. Lab Anim (NY) (2011) 2.09
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog (2011) 1.80
Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. J Immunol (2004) 1.76
STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity (2012) 1.56
Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet (2002) 1.50
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood (2004) 1.42
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques. J Virol (2010) 1.41
Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol (2003) 1.41
Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog (2010) 1.39
In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol (2010) 1.35
Molecular mechanisms of measles virus persistence. Virus Res (2005) 1.32
Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol (2002) 1.23
Morbilliviruses and human disease. J Pathol (2006) 1.22
Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model. Immunity (2002) 1.22
Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol (2011) 1.18
Measles immune suppression: lessons from the macaque model. PLoS Pathog (2012) 1.18
Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol Cell Proteomics (2010) 1.14
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. J Immunol (2005) 1.12
Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J Gen Virol (2009) 1.10
The pathogenesis of measles. Curr Opin Virol (2012) 1.09
IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol (2011) 1.08
Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J Gen Virol (2007) 1.06
Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy (2010) 1.04
Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma. Blood (2005) 1.04
Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells. Biol Blood Marrow Transplant (2008) 1.04
Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model. Xenotransplantation (2013) 1.02
Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α. Cell Metab (2013) 1.02
Rinderpest eradication: lessons for measles eradication? Curr Opin Virol (2012) 1.01
Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J Virol (2005) 1.01
RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice. Mol Cell Biol (2002) 1.00
The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol (2007) 0.99
Sertoli cell vacuolization and abnormal germ cell adhesion in mice deficient in an inositol polyphosphate 5-phosphatase. Biol Reprod (2002) 0.94
Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro. J Virol (2008) 0.93
A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol (2009) 0.90
Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res (2004) 0.90
Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J Virol (2013) 0.90
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3. Cancer Res (2004) 0.89
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol (2009) 0.87
Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy. J Mol Endocrinol (2011) 0.86
Chronic Infection of Domestic Cats with Feline Morbillivirus, United States. Emerg Infect Dis (2016) 0.85
Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus. J Virol (2014) 0.85
A prominent role for DC-SIGN+ dendritic cells in initiation and dissemination of measles virus infection in non-human primates. PLoS One (2012) 0.85
Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets. Vaccine (2012) 0.85
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates. Vaccine (2013) 0.84
Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J Gen Virol (2007) 0.83
Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol (2011) 0.83
Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells. J Gen Virol (2005) 0.82
Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J Gen Virol (2013) 0.81
Determination of spontaneous mutation frequencies in measles virus under nonselective conditions. J Virol (2012) 0.81
Paramyxovirus infections in ex vivo lung slice cultures of different host species. J Virol Methods (2013) 0.81
Pathological consequences of systemic measles virus infection. J Pathol (2015) 0.81
Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence. Vaccine (2009) 0.79
Evidence for cooperative transforming activity of the human pituitary tumor transforming gene and human T-cell leukemia virus type 1 Tax. J Virol (2007) 0.78
GNAS haploinsufficiency leads to subcutaneous tumor formation with collagen and elastin deposition and calcification. Endocr Res (2009) 0.78
New concepts in measles virus replication: getting in and out in vivo and modulating the host cell environment. Virus Res (2011) 0.77
Demodex spp. in the hair follicles of rhesus macaques (Macaca mulatta). J Med Primatol (2005) 0.76
Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase. J Gen Virol (2015) 0.76
Infection of human oligodendroglioma cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Neurovirol (2002) 0.75
Live-cell visualization of transmembrane protein oligomerization and membrane fusion using two-fragment haptoEGFP methodology. Biosci Rep (2012) 0.75